European equities traded in the US as American depositary kicked off the week higher late Monday morning, rising 0.78% to 1,700.55 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by petroleum refiner Equinor (EQNR) and internet advertising firm Criteo (CRTO), which rose 3.8% and 3.4%, respectively. They were followed by software firm SAP (SAP) and pharmaceutical company Novo Nordisk (NVO), which were up 1.4% each.

The decliners from continental Europe were led by medical device maker EDAP TMS (EDAP) and biopharmaceutical company Cellectis (CLLS), which dropped 2.8% and 2.5%, respectively. They were followed by accommodations booking company trivago (TRVG) and biotech firm BioNTech (BNTX), which lost 1.8% and 0.4%, respectively.

The gainers from the UK were led by pharmaceutical company AstraZeneca (AZN), which advanced by 2.9%. It was followed by pharmaceutical company Silence Therapeutics (SLN) and utilities company National Grid (NGG), which increased 2.4% and 2.3%, respectively.

The decliners from the UK and Ireland were led by biopharmaceutical companies Mereo BioPharma Group (MREO) and Amarin (AMRN), fell 2.9% and 1%, respectively. They were followed by communications company WPP (WPP) and hospitality company InterContinental Hotels Group (IHG), which were down 0.9% and 0.5%, respectively.